About Bullfrog AI Holdings, Inc. Warrants
https://www.bullfrogai.comBullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data.
CEO
Vininder Singh
Compensation Summary
(Year 2024)
Salary $400,000
Option Awards $230,680
Total Compensation $630,680
Industry Medical - Healthcare Information Services
Sector Healthcare
Went public January 20, 2023
Method of going public IPO
Full time employees 2
Ratings Snapshot
Rating : C
Discounted Cash Flow 5
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Market Cap $3.53 M
52w High $0.44
52w Low $0.16
P/E 0
Volume 9.32K
Outstanding Shares 11.41M
About Bullfrog AI Holdings, Inc. Warrants
https://www.bullfrogai.comBullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $83.41K ▲ | $1.59M ▲ | $-1.55M ▼ | -1.86K% ▲ | $-0.15 | $-1.55M ▼ |
| Q2-2025 | $33.26K ▲ | $1.48M ▼ | $-1.45M ▲ | -4.36K% ▼ | $-0.15 ▲ | $-1.45M ▲ |
| Q1-2025 | $0 | $2.06M ▲ | $-2.02M ▼ | 0% | $-0.21 ▼ | $-2.02M ▼ |
| Q4-2024 | $0 | $1.77M ▼ | $-1.71M ▲ | 0% | $-0.19 ▲ | $-1.71M ▲ |
| Q3-2024 | $0 | $1.82M | $-1.76M | 0% | $-0.22 | $-1.76M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.99M ▼ | $2.7M ▼ | $758.7K ▲ | $1.94M ▼ |
| Q2-2025 | $2.47M ▼ | $2.87M ▼ | $681.08K ▼ | $2.19M ▼ |
| Q1-2025 | $3.8M ▼ | $4.09M ▼ | $839.4K ▲ | $3.25M ▼ |
| Q4-2024 | $5.44M ▲ | $5.55M ▲ | $588.09K ▼ | $4.96M ▲ |
| Q3-2024 | $4.24M | $4.6M | $779.04K | $3.82M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.55M ▼ | $-1.11M ▲ | $0 | $624.25K ▲ | $-482.92K ▲ | $-1.11M ▲ |
| Q2-2025 | $-1.45M ▲ | $-1.43M ▲ | $0 | $208.68K ▲ | $-1.22M ▲ | $-1.43M ▲ |
| Q1-2025 | $-2.02M ▼ | $-1.8M ▼ | $0 | $164.07K ▼ | $-1.63M ▼ | $-1.8M ▼ |
| Q4-2024 | $-1.71M ▲ | $-1.27M ▼ | $0 | $2.47M ▲ | $1.2M ▲ | $-1.27M ▼ |
| Q3-2024 | $-1.76M | $-1.21M | $0 | $-169.03K | $-1.38M | $-1.21M |
CEO
Vininder Singh
Compensation Summary
(Year 2024)
Salary $400,000
Option Awards $230,680
Total Compensation $630,680
Industry Medical - Healthcare Information Services
Sector Healthcare
Went public January 20, 2023
Method of going public IPO
Full time employees 2
Ratings Snapshot
Rating : C
Discounted Cash Flow 5
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0